MGROF (MustGrow Biologics) EPS without NRI: $-0.07 (TTM As of Mar. 2026)


MGROF MustGrow Biologics Corp MGROF
29 GF Score
Price $0.27
! 3 Warning Signs
View Full Analysis

What is MustGrow Biologics EPS without NRI?

MustGrow Biologics MGROF 29 EPS without NRI is $-0.07 as of Mar. 2026. GuruFocus rates MGROF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review. Among 212 Agriculture companies, MustGrow Biologics ranks better than 52.83% on this metric.

MustGrow Biologics's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $-0.01. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.07.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -1.80% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for MustGrow Biologics's EPS without NRI or its related term are showing as below:

MGROF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -291.5   Med: -8.7   Max: 55.9
Current: -1.8

During the past 10 years, MustGrow Biologics's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 55.90% per year. The lowest was -291.50% per year. And the median was -8.70% per year.

MGROF's 3-Year EPS without NRI Growth Rate is ranked better than
52.83% of 212 companies
in the Agriculture industry
Industry Median: -5.45 vs MGROF: -1.80

MustGrow Biologics's EPS (Diluted) for the three months ended in Mar. 2026 was $-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.08.

MustGrow Biologics's EPS (Basic) for the three months ended in Mar. 2026 was $-0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.08.


MustGrow Biologics  (OTCPK:MGROF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


MustGrow Biologics EPS without NRI Related Terms


MustGrow Biologics EPS without NRI Historical Data

* Premium members only.

The historical data trend for MustGrow Biologics's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MustGrow Biologics EPS without NRI Chart

MustGrow Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 -0.08 -0.01 -0.06 -0.09

MustGrow Biologics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.01 -0.03 -0.01 -0.01

MGROF vs CTVA, CF, MOS: EPS without NRI Comparison

For the Agricultural Inputs subindustry, MustGrow Biologics's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MustGrow Biologics PE Ratio without NRI vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, MustGrow Biologics's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where MustGrow Biologics's PE Ratio without NRI falls into.


MGROF
29GF Score
MustGrow Biologics Corp MGROF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MustGrow Biologics EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $-0.07 mean?
MustGrow Biologics (MGROF) has a EPS without NRI of $-0.07 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on MustGrow Biologics and its competitors. According to the industry distribution chart, MustGrow Biologics ranks #100 out of 212 companies in the Agriculture industry, placing it in the top 47.2%.
Is MustGrow Biologics' EPS without NRI too high?
MustGrow Biologics' current EPS without NRI is $-0.07. Based on the distribution chart, MustGrow Biologics ranks #100 out of 212 companies in the Agriculture industry, which is above the industry midpoint. Overall, MustGrow Biologics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' EPS without NRI compare to CTVA and CF?
According to the Agriculture industry distribution chart, MustGrow Biologics ranks #100 out of 212 companies for EPS without NRI. This puts MustGrow Biologics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for an Agriculture company?
A good EPS without NRI depends on the Agriculture industry context. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on MustGrow Biologics and its competitors. MustGrow Biologics's current EPS without NRI is $-0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
MustGrow Biologics (MGROF) has a current EPS without NRI of $-0.07. The current EPS without NRI is $-0.07. MustGrow Biologics' overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current EPS without NRI is $-0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MustGrow Biologics Business Description

Other Exchanges 0C0:GermanyMGRO:Canada
Address 1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
29GF Score

Get the complete analysis for MGROF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.27
Price